1 Documents Exported
  1   Verapamil: therapeutic use
Hypertension (800992269)

Verapamil: therapeutic use
Supporting Evidence
Citation Details
Black HR, Elliott WJ, Grandits G, Gramsch P, CONVINCE Research Group, et al. Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by georgraphical region. Journal of Hypertension 23: 1099-1106, No. 5, May 2005 . Rush University Medical Center, Chicago, Illinois, USA
Journal Fulltext.
Protocol / Study ID
Trial Acronym(s):
CONVINCE (Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints)
Study Details
Design: Multicentre, randomised, double-blind
Control: Baseline comparison, drug comparison, patient comparison, geographical comparison
Phase: III
Location: USA, Canada, Spain, United Kingdom, Italy, Sweden, Germany, Bulgaria, Israel, Mexico, Czech Republic, Hungary, Poland, Slovakia, Brazil
Endpoints: Blood pressure, Cardiovascular death, Cardiovascular events, Diastolic blood pressure, Hospitalisation, Mortality, Myocardial infarction event rate, Patient compliance, Revascularisation, Stroke event rate, Systolic blood pressure
No Age
16476 adult, elderly

Patient Inclusion Criteria: Hypertensive volunteers with at least one or more additional cardiovascular risk factors.
Descriptors & Links
Adis Descriptors
Hydrochlorothiazide: therapeutic use
Hypertension: treatment
Verapamil: therapeutic use
Atenolol: therapeutic use
Related Documents
Matched on Trial Name: Controlled ONset Verapamil INvestigation of Cardiovascular EndpointsShowing 10 of 10
Best Evidence Hypertension 37: 12-18, Jan 2001
Best Evidence JAMA: the Journal of the American Medical Association 289: 2073-2082, 23-30 Apr 2003
Best Evidence American Journal of Hypertension 17: 817-822, No. 9, Sep 2004
Best Evidence Hypertension 46: 386-392, No. 2, Aug 2005
Best Evidence Lancet 366: 1545-1553, No. 9496, 29 Oct 2005
Best Evidence Journal of the American College of Cardiology 47 (Suppl. A): 361, No. 4, 21 Feb 2006
Best Evidence CMAJ: Canadian Medical Association Journal 174: 1737-1742, No. 12, 6 Jun 2006
Best Evidence Journal of Clinical Hypertension 8 (Suppl. A): 44 abstr. P-89, No. 5, 5 May 2006
Best Evidence Journal of Hypertension 25: 1543-1553, No. 8, Aug 2007
Supporting Evidence Journal of Hypertension 24 (Suppl. 4): 419, 1 Jun 2006
© 2008 Adis Data Information BV